Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Clinical Consultations™: Finding Opportunities to Improve the Management of Patients with Connective Tissue Disease-associated Pulmonary Arterial Hypertension (CTD-PAH)

Release Date: October 26, 2021
Expiration Date: October 26, 2022

Activity Overview

This Clinical Consultations^TM is a video-based program in which two experts use a case-based approach to discuss the treatment and management of connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH). In this activity, the faculty focus on the diagnosis of CTD-PAH and current treatment strategies, as well as the role of the multidisciplinary care team in optimizing care for patients with CTD-PAH. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of CTD-PAH and to improve outcomes for their patients with this disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is intended for pulmonary hypertension experts, including pulmonologists, cardiologists, and rheumatologists. Other health care professionals involved in the treatment and management of patients with CTD-PAH will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Identify screening and diagnostic tests for patients at risk of CTD-PAH
Evaluate clinical data for current and emerging therapeutic agents for the treatment of patients with CTD-PAH
Develop individualized treatment plans to address the burden of CTD-PAH using shared decision-making

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible entities

Faculty

Colleen A. McEvoy, MD
Associate Professor of Medicine
Director, Stem Cell Transplant and Oncology ICU
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine

Disclosures: Colleen A. McEvoy, MD, has no relevant financial relationships with ineligible companies.

Colin E. Diffie, MD

Colin E. Diffie, MD
Assistant Professor
Department of Internal Medicine
Washington University
St. Louis, MO

Disclosures: Colin E. Diffie, MD, has no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.